EHE – UBS rates the stock as Neutral

By Broker News | More Articles by Broker News

The FY20 update was in line with UBS expectations, with a non-cash impairment charge of $124-148m to be taken in the results.

Spot occupancy has improved to 92.7% as of June 30 as restrictions are eased.

While the company has shown strong execution, UBS expects occupancy pressures will build again as coronavirus cases re-escalate within Victoria, and potentially other states.

Neutral rating and $1.55 target maintained.

Sector: Health Care Equipment & Services.

Target price is $1.55.Current Price is $1.44. Difference: $0.11 – (brackets indicate current price is over target). If EHE meets the UBS target it will return approximately 7% (excluding dividends, fees and charges – negative figures indicate an expected loss).

Broker News

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →